Polskie Radio covers how Ozempic, made for type 2 diabetes, came to be used for weight loss. Only the headline came through, so the details are at the source.
Recap by typeshit. Full story at www.polskieradio.pl.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Dr. Regina DePietro of MU Health Care says unapproved peptides sold for research lack the safety checks Ozempic went through, and suggests asking a doctor first.
Photos online users uploaded mostly matched what they reported, but over 65% on compounded semaglutide or tirzepatide called it the brand version, Medscape reports.
Loading…